These novel results are transformational for our understanding of the molecular mechanisms mediating tau release and propagation at synaptic terminals in Alzheimer’s disease and suggest these processes could be inhibited therapeutically by the selective activation of presynaptic G-protein-coupled receptors. Here, MAPT is linked to Alzheimer disease.